These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 1993325)

  • 1. Methadone concentrations in plasma and their relationship to drug dosage.
    Wolff K; Sanderson M; Hay AW; Raistrick D
    Clin Chem; 1991 Feb; 37(2):205-9. PubMed ID: 1993325
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Can Saliva and Plasma Methadone Concentrations Be Used for Enantioselective Pharmacokinetic and Pharmacodynamic Studies in Patients With Advanced Cancer?
    George R; Haywood A; Good P; Hennig S; Khan S; Norris R; Hardy J
    Clin Ther; 2017 Sep; 39(9):1840-1848. PubMed ID: 28827023
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Developing of LC/MS method with microwave assisted extraction for determination of methadone and it major metabolite (EDDP) in the blood of patients of methadone maintenance treatment.
    Piekoszewski W; Florek E; Kobus A; Lechowicz W; Blanquart T
    Przegl Lek; 2009; 66(10):850-2. PubMed ID: 20301952
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Measuring compliance in methadone maintenance patients: use of a pharmacologic indicator to "estimate" methadone plasma levels.
    Wolff K; Hay A; Raistrick D; Calvert R; Feely M
    Clin Pharmacol Ther; 1991 Aug; 50(2):199-207. PubMed ID: 1868680
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Plasma methadone measurements and their role in methadone detoxification programs.
    Wolff K; Hay AW; Raistrick D
    Clin Chem; 1992 Mar; 38(3):420-5. PubMed ID: 1547564
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Steady-state pharmacokinetics of methadone in opioid addicts.
    Wolff K; Hay AW; Raistrick D; Calvert R
    Eur J Clin Pharmacol; 1993; 44(2):189-94. PubMed ID: 8453965
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Relationship between plasma concentrations of the l-enantiomer of methadone and response to methadone maintenance treatment.
    Meini M; Moncini M; Daini L; Giarratana T; Scaramelli D; Chericoni S; Stefanelli F; Rucci P
    Eur J Pharmacol; 2015 Aug; 760():1-6. PubMed ID: 25891369
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pharmacokinetics of methadone and its primary metabolite in 20 opiate addicts.
    de Vos JW; Geerlings PJ; van den Brink W; Ufkes JG; van Wilgenburg H
    Eur J Clin Pharmacol; 1995; 48(5):361-6. PubMed ID: 8641323
    [TBL] [Abstract][Full Text] [Related]  

  • 9. High interindividual variability of methadone enantiomer blood levels to dose ratios.
    Eap CB; Bertschy G; Baumann P; Finkbeiner T; Gastpar M; Scherbaum N
    Arch Gen Psychiatry; 1998 Jan; 55(1):89-90. PubMed ID: 9435768
    [No Abstract]   [Full Text] [Related]  

  • 10. Interindividual variability of the clinical pharmacokinetics of methadone: implications for the treatment of opioid dependence.
    Eap CB; Buclin T; Baumann P
    Clin Pharmacokinet; 2002; 41(14):1153-93. PubMed ID: 12405865
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Brain and plasma levels of methadone and their relationships to analgesic activity of methadone in rats.
    Liu SJ; Roerig DL; Wang RI
    Drug Metab Dispos; 1983; 11(4):335-8. PubMed ID: 6137339
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Subjective and objective symptoms in relation to plasma methadone concentration in methadone patients.
    Hiltunen AJ; Lafolie P; Martel J; Ottosson EC; Boreus LO; Beck O; Borg S; Hjemdahl P
    Psychopharmacology (Berl); 1995 Mar; 118(2):122-6. PubMed ID: 7617797
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Stereoselective determination of methadone and its main metabolite in serum and urine from methadone maintenance patients.
    Valentová J; Horáková R; Pechová I; Okruhlica L; Devínsky F
    Neuro Endocrinol Lett; 2006 Dec; 27 Suppl 2():130-3. PubMed ID: 17159797
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Case report: quantification of methadone-induced respiratory depression using toxicokinetic/toxicodynamic relationships.
    Mégarbane B; Declèves X; Bloch V; Bardin C; Chast F; Baud FJ
    Crit Care; 2007; 11(1):R5. PubMed ID: 17224045
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Silibinin affects the pharmacokinetics of methadone in rats.
    Pan PP; Wang J; Luo J; Wang SH; Zhou YF; Chen SZ; Du Z
    Drug Test Anal; 2018 Mar; 10(3):557-561. PubMed ID: 28643437
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Methadone distribution and excretion into breast milk of clients in a methadone maintenance programme.
    Wojnar-Horton RE; Kristensen JH; Yapp P; Ilett KF; Dusci LJ; Hackett LP
    Br J Clin Pharmacol; 1997 Dec; 44(6):543-7. PubMed ID: 9431829
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The secretion of methadone and its major metabolite in the gastric juice of humans: comparison with blood and salivary concentrations.
    Lynn RK; Olsen GD; Leger RM; Gordon WP; Smith RG; Gerber N
    Drug Metab Dispos; 1976; 4(5):504-9. PubMed ID: 10151
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Free and bound enantiomers of methadone and its metabolite, EDDP in methadone maintenance treatment: relationship to dosage?
    Lehotay DC; George S; Etter ML; Graybiel K; Eichhorst JC; Fern B; Wildenboer W; Selby P; Kapur B
    Clin Biochem; 2005 Dec; 38(12):1088-94. PubMed ID: 16289016
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Serum methadone monitoring in addicts on methadone maintenance treatment].
    Angelo HR; Kristensen F; Jepsen PW
    Ugeskr Laeger; 1988 May; 150(22):1352-5. PubMed ID: 3376313
    [No Abstract]   [Full Text] [Related]  

  • 20. Methadone enantiomer plasma levels, CYP2B6, CYP2C19, and CYP2C9 genotypes, and response to treatment.
    Crettol S; Déglon JJ; Besson J; Croquette-Krokkar M; Gothuey I; Hämmig R; Monnat M; Hüttemann H; Baumann P; Eap CB
    Clin Pharmacol Ther; 2005 Dec; 78(6):593-604. PubMed ID: 16338275
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.